Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease

被引:22
作者
Mata-Balaguer, Trinidad [1 ,2 ]
Cuchillo-Ibanez, Inmaculada [1 ,2 ]
Calero, Miguel [2 ,3 ,4 ]
Ferrer, Isidro [2 ,5 ]
Saez-Valero, Javier [1 ,2 ]
机构
[1] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Crta Alicante Valencia Km 87, Alicante 03550, Spain
[2] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
[3] Queen Sofia Fdn, Alzheimer Ctr, Ctr Nacl Invest Enfermedades Neurol CIEN Fdn, Alzheimer Dis Res Unit, Madrid, Spain
[4] Carlos III Inst Hlth, Chron Dis Programme, Madrid, Spain
[5] Univ Barcelona, Inst Neuropatol, Hosp Univ Bellvitge, Barcelona, Spain
关键词
brain; ApoE; DNMT1; methylation; MESSENGER-RNA EXPRESSION; APOLIPOPROTEIN-E; DNA METHYLATION; SYNAPTIC PLASTICITY; RECEPTOR; BRAIN; PROMOTER; LIGAND; BINDING; PROTEIN;
D O I
10.1096/fj.201700736RR
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increasing evidence indicates that altered reelin signaling could contribute to synaptic dysfunction in Alzheimer's disease (AD). We found that reelin protein and mRNA levels were increased in the AD brain (particularly at advanced Braak stages in apolipoprotein E4 noncarriers), compared with that of control subjects. The beta-amyloid (A) protein impairs reelin activity and increases reelin expression through a mechanism that is not yet understood. To explore that mechanism, we examined the effect of A beta aa 1-42 (A beta(42)) on DNA methylation of the RELN promoter and the processing of reelin receptor apolipoprotein E receptor 2 (ApoER2) in differentiated SH-SY5Y cells because ApoER2 C-terminal fragments (CTFs), generated after reelin binding, regulate reelin expression. We found that A beta(42) decreased nuclear levels of DNA-methyltransferase 1. However, RELN promoter methylation did not change in A beta(42)-treated cells or in AD brain extracts. Instead, the levels of ApoER2-CTF appeared significantly lower in A beta(42)-treated cells and in AD extracts from advanced Braak stages of apolipoprotein E4 noncarriers. Our data show that ApoER2-CTF levels are decreased, whereas reelin expression is increased in AD brain at advanced Braak stages and after A treatment, supporting the view that ApoER2-CTF exerts a modulatory role on reelin expression. -Mata-Balaguer, T., Cuchillo-Ibanez, I., Calero, M., Ferrer, I., Saez-Valero, J. Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease.
引用
收藏
页码:3536 / 3546
页数:11
相关论文
共 68 条
  • [1] Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients:: A preliminary report
    Abdolmaleky, HM
    Cheng, KH
    Russo, A
    Smith, CL
    Faraone, SV
    Wilcox, M
    Shafa, R
    Glatt, SJ
    Nguyen, G
    Ponte, JF
    Thiagalingam, S
    Tsuang, MT
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 134B (01) : 60 - 66
  • [2] Reelin-expressing neurons in the postnatal and adult human hippocampal formation
    Abraham, H
    Meyer, G
    [J]. HIPPOCAMPUS, 2003, 13 (06) : 715 - 727
  • [3] Alcántara S, 1998, J NEUROSCI, V18, P7779
  • [4] Apolipoprotein E Isoform-Specific Effects on Lipoprotein Receptor Processing
    Bachmeier, Corbin
    Shackleton, Ben
    Ojo, Joseph
    Paris, Daniel
    Mullan, Michael
    Crawford, Fiona
    [J]. NEUROMOLECULAR MEDICINE, 2014, 16 (04) : 686 - 696
  • [5] ApoER2 processing by presenilin-1 modulates reelin expression
    Balmaceda, Valeria
    Cuchillo-Ibanez, Inmaculada
    Pujadas, Lluis
    Garcia-Ayllon, Maria-Salud
    Saura, Carlos A.
    Nimpf, Johannes
    Soriano, Eduardo
    Saez-Valero, Javier
    [J]. FASEB JOURNAL, 2014, 28 (04) : 1543 - 1554
  • [6] Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3β
    Beffert, U
    Morfini, G
    Bock, HH
    Reyna, H
    Brady, ST
    Herz, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (51) : 49958 - 49964
  • [7] Reelin expression and glycosylation patterns are altered in Alzheimer's disease
    Botella-López, A
    Burgaya, F
    Gavin, R
    García-Ayllón, MS
    Gómez-Tortosa, E
    Peña-Casanova, J
    Ureña, JM
    Del Río, JA
    Blesa, R
    Soriano, E
    Sáez-Valero, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) : 5573 - 5578
  • [8] β-amyloid controls altered Reelin expression and processing in Alzheimer's disease
    Botella-Lopez, Arancha
    Cuchillo-Ibanez, Inmaculada
    Cotrufo, Tiziana
    Mok, Su San
    Li, Qiao-Xin
    Barquero, Maria-Sagrario
    Dierssen, Mara
    Soriano, Eduardo
    Saez-Valero, Javier
    [J]. NEUROBIOLOGY OF DISEASE, 2010, 37 (03) : 682 - 691
  • [9] NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES
    BRAAK, H
    BRAAK, E
    [J]. ACTA NEUROPATHOLOGICA, 1991, 82 (04) : 239 - 259
  • [10] Apolipoprotein E genotyping method by Real Time PCR, a fast and cost-effective alternative to the TaqMan® and FRET assays
    Calero, Olga
    Hortigueela, Rafael
    Bullido, Maria J.
    Calero, Miguel
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2009, 183 (02) : 238 - 240